Search Results - Keane Maccon
- Showing 1 - 17 results of 17
-
1
-
2
-
3
The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre by McVeigh, Terri Patricia, Hughes, Lauren M., Miller, Nicola, Sheehan, Margaret, Keane, Maccon, Sweeney, Karl J., Kerin, Michael J.
Published 2014Text -
4
Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy by Walsh, Elaine M., Shalaby, Aliaa, O’Loughlin, Mark, Keane, Nessa, Webber, Mark J, Kerin, Michael J., Keane, Maccon M., Glynn, Sharon A., Callagy, Grace M.
Published 2018Text -
5
Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways by Garrido, Pablo, Shalaby, Aliaa, Walsh, Elaine M., Keane, Nessa, Webber, Mark, Keane, Maccon M., Sullivan, Francis J., Kerin, Michael J., Callagy, Grace, Ryan, Aideen E., Glynn, Sharon A.
Published 2017Text -
6
A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score© by Davey, Matthew G., Jalali, Amirhossein, Ryan, Éanna J., McLaughlin, Ray P., Sweeney, Karl J., Barry, Michael K., Malone, Carmel M., Keane, Maccon M., Lowery, Aoife J., Miller, Nicola, Kerin, Michael J.
Published 2022Text -
7
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial by Janet E. Brown, Emma Rathbone, Samantha Hinsley, Walter M. Gregory, Fatma Gossiel, Helen Marshall, Roger Burkinshaw, Helen Shulver, Hasina Thandar, Gianfilippo Bertelli, Keane Maccon, Angela Bowman, Andrew M. Hanby, Richard H. Bell, David Cameron, Robert E. Coleman
Published 2017Artigo -
8
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer by McGuire, Andrew, Casey, Maire-Caitlin, Waldron, Ronan M., Heneghan, Helen, Kalinina, Olga, Holian, Emma, McDermott, Ailbhe, Lowery, Aoife J., Newell, John, Dwyer, Róisín M., Miller, Nicola, Keane, Maccon, Brown, James A.L., Kerin, Michael J.
Published 2020Text -
9
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast canc... by Davey, Matthew G., Kerin, Eoin, O'Flaherty, C., Maher, Elizabeth, Richard, Vinitha, McAnena, Peter, McLaughlin, Ray P., Sweeney, Karl J., Barry, Michael K., Malone, Carmel M., Wyns, William, Soliman, Osama, Miller, Nicola, Keane, Maccon M., Lowery, Aoife J., Kerin, Michael J.
Published 2021Text -
10
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phas... by Sonnenblick, Amir, Agbor-Tarh, Dominique, Bradbury, Ian, Di Cosimo, Serena, Azim, Hatem A., Fumagalli, Debora, Sarp, Severine, Wolff, Antonio C., Andersson, Michael, Kroep, Judith, Cufer, Tanja, Simon, Sergio D., Salman, Pamela, Toi, Masakazu, Harris, Lyndsay, Gralow, Julie, Keane, Maccon, Moreno-Aspitia, Alvaro, Piccart-Gebhart, Martine, de Azambuja, Evandro
Published 2017Text -
11
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland by Kearns, Cathriona, Feighery, Ronan, Mc Caffrey, John, Higgins, Michaela, Smith, Martina, Murphy, Verena, O’Reilly, Seamus, Horgan, Anne M., Walshe, Janice, McDermott, Ray, Morris, Patrick G., Keane, Maccon, Martin, Michael, Murphy, Conleth, Duffy, Karen, Mihai, Alina, Armstrong, John, O’Donnell, Dearbhaile M., Gallagher, William M., Kelly, Ciara M., Kelly, Catherine M.
Published 2020Text -
12
Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer “PantHER” by Keegan, Niamh M., Furney, Simon J., Walshe, Janice M., Gullo, Giuseppe, Kennedy, M. John, Smith, Diarmuid, McCaffrey, John, Kelly, Catherine M., Egan, Keith, Kerr, Jennifer, Given, Mark, O’Donovan, Peter, Hernando, Andres, Teiserskiene, Ausra, Parker, Imelda, Kay, Elaine, Farrelly, Angela, Carr, Aoife, Calzaferri, Giulio, McDermott, Ray, Keane, Maccon M., Grogan, Liam, Breathnach, Oscar, Morris, Patrick G., Toomey, Sinead, Hennessy, Bryan T.
Published 2021Text -
13
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis o... by Gullo, Giuseppe, J. Eustace, Alex, Canonici, Alexandra, M. Collins, Denis, Kennedy, Michael J., Grogan, Liam, Breathhnach, Oscar, McCaffrey, John, Keane, Maccon, Martin, Michael J., Gupta, Rajnish, Leonard, Gregory, O’Connor, Miriam, Calvert, Paula M., Donnellan, Paul, Walshe, Janice, McDermott, Enda, Scott, Kathleen, Hernando, Andres, Parker, Imelda, W. Murray, David, C. O’Farrell, Alice, Maratha, Ashwini, Dicker, Patrick, Rafferty, Mairin, Murphy, Verena, O’Donovan, Norma, M. Gallagher, William, Ky, Bonnie, Tryfonopoulos, Dimitrios, Moulton, Brian, T. Byrne, Annette, Crown, John
Published 2019Text -
14
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAI... by Sparano, Joseph A., Gray, Robert J., Makower, Della F., Albain, Kathy S., Saphner, Thomas J., Badve, Sunil S, Wagner, Lynne I., Kaklamani, Virginia G., Keane, Maccon M., Gomez, Henry L., Reddy, Pavan S., Goggins, Timothy F., Mayer, Ingrid A., Toppmeyer, Deborah L., Brufsky, Adam M., Goetz, Matthew P., Berenberg, Jeffrey L., Mahalcioiu, Catalin, Desbiens, Christine, Hayes, Daniel F., Dees, Elizabeth C., Geyer, Charles E., Olson, John A., Wood, William C, Lively, Tracy, Paik, Soonmyung, Ellis, Matthew J., Abrams, Jeffrey, Sledge, George W.
Published 2019Text -
15
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial by Albain, Kathy S, Gray, Robert J, Makower, Della F, Faghih, Amir, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Goetz, Matthew P, Olson, John A, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Wood, William C, Keane, Maccon M, Gomez, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Berenberg, Jeffrey L, Abrams, Jeffrey, Sledge, George W, Sparano, Joseph A
Published 2020Text -
16
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer by Sparano, Joseph A., Gray, Robert J., Makower, Della F., Pritchard, Kathleen I., Albain, Kathy S., Hayes, Daniel F., Geyer, Charles E., Dees, Elizabeth C., Goetz, Matthew P., Olson, John A., Lively, Tracy, Badve, Sunil S., Saphner, Thomas J., Wagner, Lynne I., Whelan, Timothy J., Ellis, Matthew J., Paik, Soonmyung, Wood, William C., Ravdin, Peter M., Keane, Maccon M., Moreno, Henry L. Gomez, Reddy, Pavan S., Goggins, Timothy F., Mayer, Ingrid A., Brufsky, Adam M., Toppmeyer, Deborah L., Kaklamani, Virginia G., Berenberg, Jeffrey L., Abrams, Jeffrey, Sledge, George W.
Published 2018Text -
17
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer by Sparano, Joseph A., Gray, Robert J., Ravdin, Peter M., Makower, Della F., Pritchard, Kathleen I., Albain, Kathy S., Hayes, Daniel F., Geyer, Charles E., Dees, Elizabeth C., Goetz, Matthew P., Olson, John A., Lively, Tracy, Badve, Sunil S., Saphner, Thomas J., Wagner, Lynne I., Whelan, Timothy J., Ellis, Matthew J., Chir, B., Paik, Soonmyung, Wood, William C., Keane, Maccon M., Gomez Moreno, Henry L., Reddy, Pavan S., Goggins, Timothy F., Mayer, Ingrid A., Brufsky, Adam M., Kaklamani, V.G., Toppmeyer, Deborah L., Kaklamani, Virginia G., Berenberg, Jeffrey L., Abrams, Jeffrey, Sledge, George W.
Published 2019Text
Search Tools:
Related Subjects
Alkaline phosphatase
Biochemistry
Biology
Bone metastasis
Bone remodeling
Bone resorption
Breast cancer
Cancer
Confidence interval
Enzyme
Gastroenterology
Hazard ratio
Internal medicine
Medicine
Metastasis
N-terminal telopeptide
Oncology
Osteocalcin
Proportional hazards model
Pyridinoline
Zoledronic acid